Burzynski Research Institute, Inc. Stock Other OTC
Equities
BZYR
US1231591058
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.83M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | - |
Net cash position 2022 | 3.38K | Net cash position 2023 | 934 | EV / Sales 2023 | - |
P/E ratio 2022 |
-3
x | P/E ratio 2023 |
-3.68
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 83-12-31 | |
Director of Finance/CFO | 46 | 12-02-29 | |
Tomasz Janicki
PRN | Corporate Officer/Principal | 58 | 12-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 83-12-31 | |
Director/Board Member | 44 | 11-09-07 | |
Director/Board Member | 60 | 21-10-05 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |